180 Life Sciences Corp.
ATNF
$1.07
-$0.01-0.93%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 194.90K | 1.15M | 676.00K | 1.98M | 2.66M |
| Total Receivables | 44.30K | 10.00K | 10.20K | 450.10K | 130.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 986.10K | 1.19M | 1.17M | 1.21M | 578.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.23M | 2.35M | 1.85M | 3.64M | 3.37M |
|
|
|||||
| Total Current Assets | 1.23M | 2.35M | 1.85M | 3.64M | 3.37M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 9.24M | 1.56M | 1.59M | 1.62M | 1.59M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 10.47M | 3.91M | 3.44M | 5.26M | 4.96M |
|
|
|||||
| Total Accounts Payable | 2.67M | 2.92M | 1.84M | 2.16M | 1.76M |
| Total Accrued Expenses | 466.30K | 667.20K | 1.42M | 1.82M | 2.65M |
| Short-term Debt | -- | -- | -- | 1.02M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 473.10K | 429.00K | 772.30K | 12.90K | 332.90K |
| Total Finance Division Other Current Liabilities | 2.77M | -- | 50.20K | 50.10K | 55.60K |
| Total Other Current Liabilities | 2.77M | -- | 50.20K | 50.10K | 55.60K |
| Total Current Liabilities | 6.38M | 4.02M | 4.08M | 5.06M | 4.81M |
|
|
|||||
| Total Current Liabilities | 6.38M | 4.02M | 4.08M | 5.06M | 4.81M |
| Long-Term Debt | 10.60K | 13.30K | 16.50K | 19.90K | 22.20K |
| Short-term Debt | -- | -- | -- | 1.02M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 341.70K | 300.00K | 299.40K | 304.70K | 278.40K |
| Total Liabilities | 6.74M | 4.33M | 4.40M | 5.39M | 5.11M |
|
|
|||||
| Common Stock & APIC | 135.96M | 130.90M | 130.35M | 130.12M | 128.82M |
| Retained Earnings | -129.24M | -128.40M | -128.41M | -127.34M | -126.12M |
| Treasury Stock & Other | -2.98M | -2.92M | -2.89M | -2.90M | -2.85M |
| Total Common Equity | 3.73M | -418.00K | -954.50K | -127.70K | -149.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.73M | -418.00K | -954.50K | -127.70K | -149.30K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.73M | -418.00K | -954.50K | -127.70K | -149.30K |
|
|
|||||
